95 related articles for article (PubMed ID: 21036732)
1. SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer.
Chen DR; Chien SY; Kuo SJ; Teng YH; Tsai HT; Kuo JH; Chung JG
Anticancer Res; 2010 Oct; 30(10):4135-40. PubMed ID: 21036732
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors.
Shyian M; Gryshkova V; Kostianets O; Gorshkov V; Gogolev Y; Goncharuk I; Nespryadko S; Vorobjova L; Filonenko V; Kiyamova R
Exp Oncol; 2011 Jun; 33(2):94-8. PubMed ID: 21716206
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
Miksicek RJ; Myal Y; Watson PH; Walker C; Murphy LC; Leygue E
Cancer Res; 2002 May; 62(10):2736-40. PubMed ID: 12019145
[TBL] [Abstract][Full Text] [Related]
6. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis.
Poola I; DeWitty RL; Marshalleck JJ; Bhatnagar R; Abraham J; Leffall LD
Nat Med; 2005 May; 11(5):481-3. PubMed ID: 15864312
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
[TBL] [Abstract][Full Text] [Related]
8. Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer.
Li X; Cao X; Li X; Zhang W; Feng Y
Cancer Sci; 2007 Oct; 98(10):1592-6. PubMed ID: 17651454
[TBL] [Abstract][Full Text] [Related]
9. [Expression of epidermal fatty acid-binding protein and fatty acid synthase in infiltrating ductal breast carcinoma].
Li H; Lü Q; Xue H; Dong LH; Saima N; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):381-4. PubMed ID: 18359695
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a transcriptional signature of breast cancer.
Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
[TBL] [Abstract][Full Text] [Related]
11. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.
Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
14. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
16. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
17. Full-term pregnancy induces a specific genomic signature in the human breast.
Russo J; Balogh GA; Russo IH
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):51-66. PubMed ID: 18199711
[TBL] [Abstract][Full Text] [Related]
18. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY; Bi Y; Liu YS; Zhou ZB
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):515-7. PubMed ID: 17147116
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma].
Pang D; Zhao X; Xue Y
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
